Search

everythinglearnresearchcommunity

for

Search:↓

Almost 40% of Greek women with acne show signs of androgen-related disorders, with adult women more likely affected.

Birth control pills and anti-androgen medications help manage hair growth, acne, and hair loss in women with PCOS.

Gut microbiota and metabolic pathways may play a key role in PCOS development.

In 2009, there were new medical devices, treatments for gynecological conditions, updated health guidelines, and legal developments in women's health.

Hair loss can indicate brain aging and potential small vessel disease, but more research is needed to understand the clinical impact.

Metformin helps with menstrual cycles and insulin levels in PCOS but is less effective for hair growth, diabetes prevention, and weight loss, and may improve fertility and reduce diabetes risk.

Women with the NIH type of PCOS have more obesity and higher risk of diabetes and heart disease than those with other types of PCOS.

Different types of PCOS have different levels of metabolic problems, with the most severe type showing the highest disturbances.

The conclusion is that androgen receptor gene polymorphism might be a marker for polycystic ovary syndrome, but more research is needed.

Minoxidil dissolves better in propylene glycol and water as temperature and propylene glycol amount increase.

Acne is a common skin condition linked to diet, hormones, and genetics, and early treatment can prevent scarring.

Experts recommend using evidence-based methods to diagnose and treat hirsutism, focusing on symptoms and underlying causes.

Childhood obesity is rising globally due to various factors, and early prevention and healthy lifestyle changes are crucial.

PCOS is common among Chinese women of reproductive age and linked to serious metabolic and reproductive issues, especially in obese women.

PCOS is a complex disorder in women that can lead to various health risks and requires personalized treatment.

Lifestyle changes can improve body composition, excess male hormone levels, and insulin resistance in women with PCOS.

People with PCOS, especially if obese, often have NAFLD, linked to obesity, insulin resistance, and high androgen levels.

Women with PCOS may take longer to get pregnant but can have a normal family size, and should manage their overall health to reduce long-term health risks.

Treatment of acromegaly can improve women's reproductive health issues caused by hormonal imbalances or tumors.

Oxidative stress is a key factor in the development of Polycystic Ovary Syndrome, and weight management can improve symptoms.

Metformin and rosiglitazone improve blood vessel function in women with PCOS, with metformin also reducing insulin resistance and testosterone levels.

Spironolactone improved blood vessel function and cholesterol levels in non-obese women with PCOS.

Melatonin improved mental health and metabolism in women with PCOS.

Women with PCOS are more likely to have fatty liver disease, especially if they have metabolic problems.

Women with PCOS are more likely to have insulin resistance and obesity, especially those with the most severe type I PCOS.

Metformin and rosiglitazone both improved insulin use and hormonal symptoms in women with PCOS.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Women with PCOS have higher levels of AMH in their blood and follicles, and this can help predict their risk of overreaction to fertility treatments.

The combination therapy improved PCOS symptoms in both obese and non-obese women, with weight loss in the obese group.

Higher thyroid hormone levels may be linked to certain types of polycystic ovary syndrome.